Aethlon Medical Statistics

Total Valuation

Aethlon Medical has a market cap or net worth of $8.43 million. The enterprise value is $4.33 million.

Market Cap	8.43M
Enterprise Value	4.33M

Important Dates

The last earnings date was Wednesday, February 12, 2025, after market close.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Aethlon Medical has 14.46 million shares outstanding. The number of shares has increased by 291.02% in one year.

Current Share Class	14.46M
Shares Outstanding	14.46M
Shares Change (YoY)	+291.02%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.81%
Owned by Institutions (%)	3.63%
Float	13.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.88
P/TBV Ratio	1.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.80, with a Debt / Equity ratio of 0.17.

Current Ratio	2.80
Quick Ratio	2.72
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -160.04% and return on invested capital (ROIC) is -89.86%.

Return on Equity (ROE)	-160.04%
Return on Assets (ROA)	-72.47%
Return on Invested Capital (ROIC)	-89.86%
Return on Capital Employed (ROCE)	-206.96%
Revenue Per Employee	n/a
Profits Per Employee	-$682,758
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.64% in the last 52 weeks. The beta is 1.89, so Aethlon Medical's price volatility has been higher than the market average.

Beta (5Y)	1.89
52-Week Price Change	-64.64%
50-Day Moving Average	0.63
200-Day Moving Average	0.50
Relative Strength Index (RSI)	41.56
Average Volume (20 Days)	729,331

Short Selling Information

The latest short interest is 1.37 million, so 9.51% of the outstanding shares have been sold short.

Short Interest	1.37M
Short Previous Month	1.74M
Short % of Shares Out	9.51%
Short % of Float	10.11%
Short Ratio (days to cover)	0.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.83M
Pretax Income	-12.21M
Net Income	-9.56M
EBITDA	-9.49M
EBIT	-9.83M
Earnings Per Share (EPS)	-$1.01

Full Income Statement

Balance Sheet

The company has $4.83 million in cash and $724,848 in debt, giving a net cash position of $4.10 million or $0.28 per share.

Cash & Cash Equivalents	4.83M
Total Debt	724,848
Net Cash	4.10M
Net Cash Per Share	$0.28
Equity (Book Value)	4.33M
Book Value Per Share	0.31
Working Capital	3.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.54 million and capital expenditures -$7,099, giving a free cash flow of -$8.55 million.

Operating Cash Flow	-8.54M
Capital Expenditures	-7,099
Free Cash Flow	-8.55M
FCF Per Share	-$0.59

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Aethlon Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-291.02%
Shareholder Yield	-291.02%
Earnings Yield	-113.33%
FCF Yield	-101.32%

Analyst Forecast

The average price target for Aethlon Medical is $7.00, which is 1,099.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	1,099.86%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 5, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Oct 5, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1